GB Patent

GB9027055D0 — Organic compounds

Assigned to Sandoz AG · Expires 1991-02-06 · 35y expired

What this patent protects

6,7-Di(C1-4alkoxy)-1-[3,5-di(C1-4alkoxy)phenyl]-3,4-dihydro-3-hydroxy- methyl-isoquinolines , their physiologically-hydrolysable and -acceptable esters and acid addition salts thereof are novel. The said compounds and esters and pharmaceutically acceptable acid addition salts the…

USPTO Abstract

6,7-Di(C1-4alkoxy)-1-[3,5-di(C1-4alkoxy)phenyl]-3,4-dihydro-3-hydroxy- methyl-isoquinolines , their physiologically-hydrolysable and -acceptable esters and acid addition salts thereof are novel. The said compounds and esters and pharmaceutically acceptable acid addition salts thereof are useful as pharmaceuticals, e.g. in the treatment of asthma.

Drugs covered by this patent

Patent Metadata

Patent number
GB9027055D0
Jurisdiction
GB
Classification
—
Expires
1991-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Sandoz AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.